SUPRAN BRYAN sold ALNY
October 2, 2026 · Form 4 insider transaction
SUPRAN BRYAN sold 1,758 shares of Alnylam Pharmaceuticals, Inc. at $226.88 per share, a transaction worth $398.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,758
Price
$226.88
Total value
$398.9K
InsiderSUPRAN BRYAN
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 2, 2026
Filing dateOctober 6, 2026
Shares owned after12,807
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units.